| Literature DB >> 35665318 |
Ehab Shabo1, Simon Brandecker1, Shaleen Rana1, Gregor Bara1, Jasmin E Scorzin1, Lars Eichhorn2, Hartmut Vatter1, Mohammed Banat1.
Abstract
Objective: Dorsal instrumentation of the cervical spine is an established treatment in spine surgery. However, careful planning is required, particularly in elderly patients. This study evaluates early clinical outcomes in geriatric patients undergoing complex spine surgery.Entities:
Keywords: CCI and CDG scores; cervical dorsal instrumentation; comorbidities; complication rate; geriatric patients
Year: 2022 PMID: 35665318 PMCID: PMC9157765 DOI: 10.3389/fmed.2022.824047
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Baseline data.
|
|
|
|---|---|
| 78 ± 7.12 | |
|
| |
| Male | 93 (60.78) |
| Female | 60 (39.21) |
| 25 ± 3.54 | |
|
| |
| 1&2 | 51 (33.33) |
| 3&4 | 102 (66.66) |
|
| |
| Arterial hypertension | 98 (64.05) |
| Coronary heart disease | 30 (19.6) |
| Atrial fibrillation | 30 (19.6) |
| Diabetes mellitus | 34 (22.22) |
| Kidney disease | 22 (14.37) |
| History of PE/DVT/COPD | 24 (15.68) |
| Heart insufficiency | 7 (4.57) |
| Cardiomyopathy/Valve disease | 18 (11.76) |
| 16 ± 21.44 | |
| 213 [154–266] | |
|
| |
| 1. Level | 41 (26.79) |
| 2. Levels | 19 (12.41) |
| 3. Levels and more | 93 (60.78) |
|
| |
| Upper cervical spine | 65 (42.48) |
| Subaxial | 88 (57.51) |
|
| |
| Trauma | 82 (53.59) |
| Degenerative | 46 (30.06) |
| Tumor | 15 (9.80) |
| Infection | 10 (6.53) |
|
| |
|
| 125 (81.7) |
|
| |
| Symptomatic vertebral artery injury | 5 (3.26) |
| Wound infection | 8 (5.22) |
| Hematoma | 1 (0.65) |
|
| |
| Pneumonia | 6 (3.92) |
| PE/DVT | 3 (1.96) |
| Sepsis | 2 (1.3) |
| Death (30 day mortality) | 3 (1.96) |
|
| |
| Grade II | 11 (7.18) |
| Grade III | 9 (5.88) |
| Grade IV | 5 (3.26) |
| Grade V | 3 (1.96) |
ASA, American Society of Anesthesiology; BMI, Body Mass Index; COPD, chronic obstructive pulmonary disease; DVT, deep vein thrombosis; min., minutes; No., number; PE, pulmonary embolism; q1–q3, first quartile–third quartile; SD, standard deviation; yrs., years.
Comparison of patients without postoperative complications vs. surgery-related complications and/or adverse events.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| 125 | 14 | 14 | ||
| 77 ± 7.3 | 79.6 ± 5.9 | 80 ± 6.4 | 0.304 | 0.141 | |
|
| 50/75 | 5/9 | 5/9 | 1.00 | 1.00 |
| 24.9 ± 3.5 | 23.9 ± 3.6 | 24.4 ± 3.7 | 0.317 | 0.665 | |
|
| 0.557 | 0.548 | |||
| 1 or 2 | 42 | 6 | 3 | ||
| 3 or 4 | 83 | 8 | 11 | ||
|
| 0.132 | 0.071 | |||
| 1 or 2 | 57 | 5 | 4 | ||
| >3 | 68 | 9 | 10 | ||
|
| 0.465 | 1.00 | |||
| Arterial hypertension | 83 | 7 | 8 | 0.247 | 0.557 |
| Coronary heart disease | 24 | 2 | 4 | 1.00 | 0.481 |
| Atrial fibrillation | 22 | 5 | 3 | 0.147 | 0.717 |
| Diabetes mellitus | 24 | 7 | 3 | 0.016 | 0.735 |
| Kidney disease | 13 | 6 | 3 | 0.004 | 0.205 |
| History of PE/DVT/COPD | 19 | 2 | 3 | 1.00 | 0.465 |
| 15 [9–30] | 20 [13–51] | 26 [8–41] | 0.182 | 0.981 | |
| 212.3 ± 75.6 | 215.1 ± 57.8 | 217.9 ± 80.2 | 0.892 | 0.793 | |
|
| 0.035 | 0.115 | |||
| 1–2 level | 55 | 1 | 4 | ||
| >3 levels | 70 | 13 | 10 | ||
|
| 0.262 | 0.092 | |||
| Upper cervical spine | 58 | 4 | 3 | ||
| Subaxial | 67 | 10 | 11 | ||
|
| 0.227 | 0.077 | |||
| Trauma | 69 | 7 | 6 | ||
| Degenerative | 38 | 5 | 3 | ||
| Tumor | 13 | 0 | 2 | ||
| Infection | 5 | 2 | 3 |
AEs, adverse events; ASA, American Society of Anesthesiology; BMI, body mass index; ds, days; CCI, Charlson comorbidity index; compl., complication; COPD, chronic obstructive pulmonary disease; DVT, deep vein thrombosis; PE, pulmonary embolism; pts., patients; q1-q3, first quartile – third quartile; surg.-rel., surgery-related; w/o, without; yrs., years.